Public market insider buying at Wesana Health Holdings (WESA)

Public market insider buying at Wesana Health Holdings (C:WESA)

The K2 Principal Fund L.P., a 10% Holder, acquired 113,800 Common Shares on a direct ownership basis at prices ranging from $1.536 to $1.698 between December 13th, 2021 and December 17th, 2021. This represents a $179,838 investment into the company's shares and an account share holdings change of 6.1%.

Wesana Health Holdings is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma. Wesana Health Holdings Inc. (WESA) has below median officer and director direct ownership compared to its micro-cap peers in the market, based on our estimate using SEDI data. According to recent regulatory filings, one insider has invested a total amount of $179,838.